Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking
The study indicates that patients with progressive KC maintain stable vr-QoL after undergoing CXL. Based on our findings, we suggest considering very early CXL treatment for KC patients that are at high risk of progression.
Authors
- Johannes Steinberg (ORCID: https://orcid.org/0000-0002-3091-9347)
- Toam Katz (ORCID: https://orcid.org/0000-0002-3160-0231)
- Андреас Фрингс (ORCID: https://orcid.org/0000-0001-8977-4261)
- Vasyl Druchkiv (ORCID: https://orcid.org/0000-0002-6344-4480)
- P. Fischer (ORCID: https://orcid.org/0000-0003-3766-9085)
- S. Linke
Institutions
- Universität Hamburg (DE)
- MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Martini-Klinik (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1007/s10792-024-03400-6
- Citations
- 2
- Primary Topic
- Corneal surgery and disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.72